Key result
Elevated triglycerides are linked to ~45% higher CAD risk in men with low HDL-C.
Why the study?
Do elevated fasting triglyceride levels increase the risk of coronary artery disease in primary prevention patients when stratified by sex and HDL-C?
Cohort (n=1,268,651)
Do elevated fasting triglyceride levels increase the risk of coronary artery disease in primary prevention patients when stratified by sex and HDL-C?
Elevated triglycerides are associated with increased CAD risk in primary prevention patients only when HDL-C is < 1.8 mmol/L, with different risk thresholds for men and women.
Aims The potential impact of high‐density lipoprotein cholesterol (HDL‐C) on the relationship between triglycerides (TGs) and coronary artery disease (CAD) remains uncertain. We investigated the association between untreated fasting TG levels and CAD risk stratified by HDL‐C and sex. Materials and Methods This retrospective study analysed data from a JMDC Inc. claims based database from April 2008 to April 2022, which included information on administrative claims and annual health checkups. Multivariable Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between TG levels and CAD. CAD was defined by validated methods using both disease and procedure codes. Results During a mean follow‐up of 5.55 ± 2.39 years among 1,268,651 participants, 5490 men and 665 women experienced CAD events. For participants with HDL‐C ≥ 1.8 mmol/L, no increase was observed in CAD risk associated with TG levels in either men or women. However, in those with HDL‐C < 1.8 mmol/L, CAD risk increased in men with TG > 1.5 mmol/L (HR, 1.45; 95% CI, 1.08–1.93) and in women with TG > 1.00 mmol/L (HR, 2.62; 95% CI, 1.26–5.46) compared to TG < 0.50 mmol/L. Conclusions Triglyceride levels were associated with an increased risk of CAD in both men and women, particularly in patients with HDL‐C < 1.8 mmol/L, among primary prevention participants not on lipid‐lowering drugs. Optimal cutoff or target therapeutic values based on patient characteristics need to be established to prevent CAD from an early stage.
No takes yet. Share an insight, caveat, or question.
Oe et al. (2026) conducted a cohort in Coronary artery disease (n=1,268,651). Untreated fasting triglyceride levels vs. TG < 0.50 mmol/L was evaluated on Coronary artery disease (HR 1.45, 95% CI 1.08-1.93). In participants with HDL-C < 1.8 mmol/L, higher triglycerides increased CAD risk in men (HR 1.45; 95% CI 1.08-1.93) and women (HR 2.62; 95% CI 1.26-5.46) compared to TG < 0.50 mmol/L.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: